![These highlights do not include all the information needed to use EMFLAZA® safely and effectively. See full prescribing information for EMFLAZA. EMFLAZA® (deflazacort) tablets, for oral use EMFLAZA® (deflazacort) oral suspension Initial These highlights do not include all the information needed to use EMFLAZA® safely and effectively. See full prescribing information for EMFLAZA. EMFLAZA® (deflazacort) tablets, for oral use EMFLAZA® (deflazacort) oral suspension Initial](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=emflaza-22.jpg&id=696295)
These highlights do not include all the information needed to use EMFLAZA® safely and effectively. See full prescribing information for EMFLAZA. EMFLAZA® (deflazacort) tablets, for oral use EMFLAZA® (deflazacort) oral suspension Initial
![Dollar-a-dose, off-patent drug being marketed in the US for $89,000 as a muscular dystrophy treatment | Boing Boing Dollar-a-dose, off-patent drug being marketed in the US for $89,000 as a muscular dystrophy treatment | Boing Boing](https://i0.wp.com/boingboing.net/wp-content/uploads/2017/02/050-056c026d-1c66-4d42-9fae-a8e96df290c5-1020x1414.jpg?fit=1350%2C560&ssl=1)
Dollar-a-dose, off-patent drug being marketed in the US for $89,000 as a muscular dystrophy treatment | Boing Boing
![FDA Approves EMFLAZA™ (deflazacort) Tablets and Oral Suspension for the Treatment of Duchenne Muscular Dystrophy in Patients 5 Years and Older | Business Wire FDA Approves EMFLAZA™ (deflazacort) Tablets and Oral Suspension for the Treatment of Duchenne Muscular Dystrophy in Patients 5 Years and Older | Business Wire](https://mms.businesswire.com/media/20170209006410/en/569105/5/EMFLAZA_%28deflazacort%29_Tablets_Photo_FINAL.jpg)